A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Recruiting · NCT07765888 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 3 | 2026-09-04 | NCT07765888 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AllerVie Clinical Research | Panama City | United States | 2 |
| GCP Research , Global Clinical Professionals | St. Petersburg | United States | 1 |
| Northridge Clinical Trials | Northridge | United States | 14 |